APA (7th ed.) Citation

Dasari, V., Beckett, K., Horsefield, S., Ambalathingal, G., & Khanna, R. (2022). A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice. PLoS Pathogens, 18(6), 1. https://doi.org/10.1371/journal.ppat.1010403

Chicago Style (17th ed.) Citation

Dasari, Vijayendra, Kirrilee Beckett, Shane Horsefield, George Ambalathingal, and Rajiv Khanna. "A Bivalent CMV Vaccine Formulated with Human Compatible TLR9 Agonist CpG1018 Elicits Potent Cellular and Humoral Immunity in HLA Expressing Mice." PLoS Pathogens 18, no. 6 (2022): 1. https://doi.org/10.1371/journal.ppat.1010403.

MLA (9th ed.) Citation

Dasari, Vijayendra, et al. "A Bivalent CMV Vaccine Formulated with Human Compatible TLR9 Agonist CpG1018 Elicits Potent Cellular and Humoral Immunity in HLA Expressing Mice." PLoS Pathogens, vol. 18, no. 6, 2022, p. 1, https://doi.org/10.1371/journal.ppat.1010403.